Citadel Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $159M | Sell |
2,218,400
-1,342,600
| -38% | -$103M | 0.03% | 554 |
|
|
2025
Q4 | $283M | Sell |
3,561,000
-2,964,800
| -45% | -$234M | 0.04% | 365 |
|
|
2025
Q3 | $492M | Buy |
6,525,800
+1,865,500
| +40% | +$128M | 0.07% | 190 |
|
|
2025
Q2 | $321M | Sell |
4,660,300
-294,000
| -6% | -$19.3M | 0.06% | 265 |
|
|
2025
Q1 | $336M | Sell |
4,954,300
-64,700
| -1% | -$3.87M | 0.06% | 226 |
|
|
2024
Q4 | $225M | Sell |
5,019,000
-2,657,900
| -35% | -$149M | 0.04% | 364 |
|
|
2024
Q3 | $483M | Buy |
7,676,900
+3,298,300
| +75% | +$192M | 0.09% | 144 |
|
|
2024
Q2 | $259M | Sell |
4,378,600
-39,700
| -0.9% | -$2.48M | 0.05% | 273 |
|
|
2024
Q1 | $352M | Sell |
4,418,300
-415,000
| -9% | -$31.7M | 0.07% | 202 |
|
|
2023
Q4 | $382M | Sell |
4,833,300
-387,800
| -7% | -$27.6M | 0.08% | 163 |
|
|
2023
Q3 | $365M | Buy |
5,221,100
+2,763,400
| +112% | +$196M | 0.08% | 148 |
|
|
2023
Q2 | $170M | Buy |
2,457,700
+559,600
| +29% | +$39.8M | 0.04% | 378 |
|
|
2023
Q1 | $141M | Buy |
1,898,100
+227,100
| +14% | +$19M | 0.03% | 455 |
|
|
2022
Q4 | $156M | Sell |
1,671,000
-295,500
| -15% | -$28.5M | 0.04% | 436 |
|
|
2022
Q3 | $188M | Buy |
1,966,500
+158,400
| +9% | +$15.7M | 0.04% | 325 |
|
|
2022
Q2 | $168M | Sell |
1,808,100
-417,200
| -19% | -$40.7M | 0.04% | 343 |
|
|
2022
Q1 | $225M | Sell |
2,225,300
-1,299,300
| -37% | -$136M | 0.05% | 299 |
|
|
2021
Q4 | $364M | Buy |
3,524,600
+605,600
| +21% | +$56M | 0.07% | 166 |
|
|
2021
Q3 | $248M | Sell |
2,919,000
-675,100
| -19% | -$56.5M | 0.05% | 275 |
|
|
2021
Q2 | $300M | Buy |
3,594,100
+803,500
| +29% | +$65.8M | 0.07% | 196 |
|
|
2021
Q1 | $210M | Buy |
2,790,600
+559,051
| +25% | +$40.7M | 0.05% | 269 |
|
|
2020
Q4 | $152M | Buy |
2,231,549
+28,049
| +1% | +$1.82M | 0.04% | 361 |
|
|
2020
Q3 | $129M | Buy |
2,203,500
+53,400
| +2% | +$3.32M | 0.04% | 339 |
|
|
2020
Q2 | $140M | Buy |
2,150,100
+195,800
| +10% | +$12.3M | 0.05% | 279 |
|
|
2020
Q1 | $116M | Buy |
1,954,300
+143,800
| +8% | +$9.6M | 0.05% | 290 |
|
|
2019
Q4 | $135M | Sell |
1,810,500
-436,400
| -19% | -$30.6M | 0.06% | 290 |
|
|
2019
Q3 | $142M | Buy |
2,246,900
+693,400
| +45% | +$41.1M | 0.07% | 253 |
|
|
2019
Q2 | $84.7M | Buy |
1,553,500
+154,400
| +11% | +$8.31M | 0.04% | 469 |
|
|
2019
Q1 | $75.5M | Sell |
1,399,100
-152,800
| -10% | -$9.43M | 0.04% | 494 |
|
|
2018
Q4 | $102M | Sell |
1,551,900
-23,300
| -1% | -$1.74M | 0.06% | 318 |
|
|
2018
Q3 | $124M | Sell |
1,575,200
-100,000
| -6% | -$7.15M | 0.06% | 335 |
|
|
2018
Q2 | $108M | Buy |
1,675,200
+827,900
| +98% | +$54.6M | 0.05% | 338 |
|
|
2018
Q1 | $52.7M | Sell |
847,300
-31,100
| -4% | -$2.23M | 0.03% | 574 |
|
|
2017
Q4 | $63.7M | Buy |
878,400
+465,200
| +113% | +$33.8M | 0.04% | 506 |
|
|
2017
Q3 | $33.6M | Sell |
413,200
-114,600
| -22% | -$9.07M | 0.03% | 750 |
|
|
2017
Q2 | $42.5M | Sell |
527,800
-519,600
| -50% | -$41M | 0.04% | 574 |
|
|
2017
Q1 | $82.2M | Sell |
1,047,400
-133,200
| -11% | -$10.6M | 0.08% | 250 |
|
|
2016
Q4 | $93.2M | Buy |
1,180,600
+788,600
| +201% | +$63.8M | 0.09% | 188 |
|
|
2016
Q3 | $34.9M | Buy |
392,000
+103,100
| +36% | +$9.73M | 0.04% | 565 |
|
|
2016
Q2 | $27.7M | Buy |
288,900
+50,200
| +21% | +$5M | 0.03% | 594 |
|
|
2016
Q1 | $24.8M | Sell |
238,700
-126,900
| -35% | -$12.3M | 0.03% | 628 |
|
|
2015
Q4 | $35.7M | Buy |
365,600
+104,800
| +40% | +$10.3M | 0.04% | 540 |
|
|
2015
Q3 | $25.2M | Sell |
260,800
-35,800
| -12% | -$3.76M | 0.02% | 754 |
|
|
2015
Q2 | $31.1M | Sell |
296,600
-11,900
| -4% | -$1.22M | 0.03% | 739 |
|
|
2015
Q1 | $31.8M | Buy |
308,500
+32,800
| +12% | +$3.32M | 0.03% | 713 |
|
|
2014
Q4 | $26.6M | Buy |
275,700
+96,900
| +54% | +$8.54M | 0.03% | 783 |
|
|
2014
Q3 | $14.2M | Buy |
178,800
+83,800
| +88% | +$6.61M | 0.01% | 1128 |
|
|
2014
Q2 | $7.16M | Sell |
95,000
-39,400
| -29% | -$2.98M | 0.01% | 1539 |
|
|
2014
Q1 | $10.1M | Sell |
134,400
-117,200
| -47% | -$8.28M | 0.01% | 1262 |
|
|
2013
Q4 | $18M | Buy |
251,600
+180,800
| +255% | +$11.6M | 0.02% | 859 |
|
|
2013
Q3 | $4.02M | Sell |
70,800
-113,100
| -62% | -$6.74M | 0.01% | 1753 |
|
|
2013
Q2 | $10.5M | Buy |
+183,900
| New | +$10.7M | 0.02% | 1039 |
|
Other funds holding CVS
VCM
VPM
Citadel Advisors's CVS Position: Q1 2026 in Review
Citadel Advisors increased its CVS Health (CVS) stake by 51% in Q1 2026, buying an estimated $141M and bringing the position to 5,428,043 shares worth $390M. The position accounts for 0.06% of the portfolio, ranked #233.
Citadel Advisors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $564M in Q2 2025. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Citadel Advisors held 5,428,043 shares of CVS Health worth $390M as of Q1 2026.
- Citadel Advisors bought 1,826,690 CVS Health shares in Q1 2026, an estimated $141M.
- CVS Health made up 0.06% of Citadel Advisors's portfolio in Q1 2026, its #233 holding.
- Citadel Advisors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's CVS Health position peaked at $564M in Q2 2025.
- 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.